ABX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ABX is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has bullish technical structure and hedge funds are buying, but analyst sentiment is only Neutral with a recent price target cut, earnings quality looks mixed with revenue growth but weaker net income and EPS, and there is no strong catalyst or proprietary buy signal today. Given the current setup, the better call is to hold and wait for a cleaner long-term entry rather than buy aggressively now.
ABX is in a short-term uptrend. The moving averages are bullish with SMA_5 above SMA_20 above SMA_200, which supports positive momentum. MACD histogram is above zero but contracting, suggesting upside momentum is still present but losing strength. RSI_6 at 68.693 is near overbought territory but still labeled neutral here, so it does not yet show a strong reversal signal. Price at 9.81 is above pivot 9.329 and near resistance at 9.86, meaning upside may be capped near term. Support sits at 9.00 and 8.798. The technical picture is constructive, but not strong enough to justify an urgent long-term buy at this level.
["Hedge funds are buying, with buying amount up 182.18% over the last quarter.", "Technical trend is bullish with SMA_5 > SMA_20 > SMA_200.", "Revenue in 2025/Q4 increased 116.48% YoY, showing strong top-line growth.", "Gross margin improved to 82.89%, indicating strong operating economics.", "Options positioning is skewed toward calls, with a low put-call ratio of 0.3.", "The stock is trading above its pivot level, suggesting near-term strength."]
["Piper Sandler cut the price target to $9.50 from $11 and kept a Neutral rating.", "Analyst sentiment has weakened, with a downgrade to Neutral in March and another target cut in April.", "Net income fell 139.58% YoY and EPS dropped 131.82% YoY in the latest quarter.", "No news catalyst in the recent week.", "No recent congress trading data available.", "SwingMax has no recent signal and AI Stock Picker shows no signal today.", "Price is near resistance at 9.86, limiting immediate upside."]
In 2025/Q4, Abacus Global Management posted very strong revenue growth, with revenue rising to 71,898,514, up 116.48% YoY. Gross margin also improved to 82.89%, which is a positive sign for profitability quality. However, net income fell sharply to 7,226,649, down 139.58% YoY, and EPS dropped to 0.07, down 131.82% YoY. That means the latest quarter season showed strong sales growth but weaker bottom-line performance, so the business is growing but not translating that growth cleanly into earnings yet.
Wall Street is cautious on ABX. Piper Sandler downgraded the stock from Overweight to Neutral on 2026-03-13 and then lowered the price target from $11 to $9.50 on 2026-04-07 while keeping Neutral. The pros view is that much of the upside from the prior run-up is already reflected in the stock and the company is still operating well enough for a neutral stance. The cons view is that asset-manager headwinds, scrutiny on private credit, redemptions, and a softer capital-markets backdrop could pressure sentiment. Overall, analysts are not recommending aggressive buying at current levels.
